Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
JAMA Ophthalmology
|
March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA
|
February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
Ophthalmology
|
May 14, 2021
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH
Clement K Chan, Calvin E Mein, Adam R Glassman, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Dennis M Marcus, Paolo S Silva, Danni Liu, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Paolo S Silva, Dennis M Marcus, Danni Liu, et al.
Ophthalmology. Retina
|
October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)
Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Ophthalmology. Retina
|
November 20, 2025
Risk Factors and Systemic Outcomes in Patients with Retinal Artery Occlusion
Austen N Knapp, Matthew J Schulgit, Sumit Sharma, et al.
JAMA Ophthalmology
|
July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Jeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science
|
May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)
Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
The Cochrane Database of Systematic Reviews
|
September 16, 2014
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
JAMA Ophthalmology
|
March 30, 2021
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
JAMA
|
February 7, 2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Raj K Maturi, Adam R Glassman, Kristin Josic, et al.
Ophthalmology
|
May 14, 2021
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH
Clement K Chan, Calvin E Mein, Adam R Glassman, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time
Dennis M Marcus, Paolo S Silva, Danni Liu, et al.
JAMA Ophthalmology
|
August 18, 2022
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time
Paolo S Silva, Dennis M Marcus, Danni Liu, et al.
Ophthalmology. Retina
|
October 10, 2021
A Randomized Trial of Photobiomodulation Therapy for Center-Involved Diabetic Macular Edema with Good Visual Acuity (Protocol AE)
Judy E Kim, Adam R Glassman, Kristin Josic, et al.
Ophthalmology. Retina
|
November 20, 2025
Risk Factors and Systemic Outcomes in Patients with Retinal Artery Occlusion
Austen N Knapp, Matthew J Schulgit, Sumit Sharma, et al.
JAMA Ophthalmology
|
July 26, 2018
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
Jeffrey G Gross, Adam R Glassman, Danni Liu, et al.
Ophthalmology Science
|
May 1, 2026
Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)
Andrew J Barkmeier, Thu P Vu, Michael Elman, et al.
The Cochrane Database of Systematic Reviews
|
September 16, 2014
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
Lorenzo Moja, Ersilia Lucenteforte, Koren H Kwag, et al.
Page
of 12